Aequus Announces First Canadian Cataract Procedures Using Zepto Capsulotomy System

Aequus Pharmaceuticals (TSXV:AQS) has announced that the first four cataract procedures in Canada using the Zepto Capsulotomy System have been completed.

As quoted in the press release:

 Dr. Ike Ahmed is world-renowned for his skills in the diagnosis and surgical treatment of highly complex eye diseases. He is recognized as being one of the most experienced complex eye surgeons in the world and has trained numerous surgeons in innovative surgical techniques.

“The creation of a consistent, circular, well-centered and sized capsulotomy for every patient is every cataract surgeon’s dream.  Our first experience with Zepto was flawless with great intraoperative performance.  We look forward to more experience and data in our evaluation of this promising technology,” said Dr. Ike Ahmed.

“We are absolutely delighted with the introduction of Zepto in Canada at a leading centre for cataract procedures in Canada, and thank Dr. Ahmed and his team for their remarkable enthusiasm,” said Doug Janzen, CEO and Chairman of Aequus Pharmaceuticals. “All four cases were performed with great outcomes: perfect capsulorhexis’ within the expected timeframe. We look forward to our continued introduction of Zepto to surgeons across Canada.”

About Zepto Precision Pulse Capsulotomy System

The Zepto capsulotomy system provides consistent, high quality anterior lens capsulotomies during cataract surgery in a convenient, cost-effective, disposable format. One of the key features is a collapsible super-elastic nitinol capsulotomy ring element with micron scale elements to create the unique and strong Zepto capsulotomy edge. It also has a clear silicone suction cup to enable suction and generate Zepto’s proprietary capsulotomy action and to allow Zepto capsulotomies on the patient’s individual visual axis.  The AMA has recently given a category III code in the US as they see the distinctive application and benefit of aligning on the patient’s own visual axis.

Click here to read the full press release.